TORONTO, ON (Jan. 24, 2013) - ScarX Therapeutics, a start-up company commercializing a groundbreaking treatment to dramatically reduce post-operation scarring, is receiving a $250,000 investment from Ontario Centres of Excellence.
This story was covered in Yonge Street Media on January 30, 2013.
ScarX, a topical medication, emerged from Dr. Benjamin Alman's research. Alman, head of orthopedic surgery at the Hospital for Sick Children, is developing his invention in conjunction with MaRS Innovation.
Each year, doctors worldwide perform 240 million surgeries. Currently, no clinically-proven prescription ...
January 24, 2013
in Funding or Fundraising-Announcements, Government Partners, Media Coverage, Member Institutions, News, Partnerships, Portfolio, ScarX Therapeutics, Start-Up Companies, The Hospital for Sick Children (SickKids)
Read more